Expression of BCR/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias.
about
CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosisThe Ews-ERG fusion protein can initiate neoplasia from lineage-committed haematopoietic cells.Glioblastoma cancer stem cells: Biomarker and therapeutic advancesBreast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signatureRequirement of c-Myb for p210(BCR/ABL)-dependent transformation of hematopoietic progenitors and leukemogenesisChronic myeloid leukemia: mechanisms of blastic transformationImmature B-cell progenitors survive oncogenic stress and efficiently initiate Ph+ B-acute lymphoblastic leukemiaNormal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?Disrupting the CD47-SIRPĪ± anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors.Absence of the transcription factor CCAAT enhancer binding protein alpha results in loss of myeloid identity in bcr/abl-induced malignancy.Right on target: eradicating leukemic stem cells.Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cellsCell Regulation of Proliferation and Differentiation ex vivo for Cells Containing Ph Chromosome in Chronic Myeloid LeukemiaDiverging fates of cells of origin in acute and chronic leukaemia.Distinct roles for long-term hematopoietic stem cells and erythroid precursor cells in a murine model of Jak2V617F-mediated polycythemia vera.Normal and leukaemic stem cells.Cancer stem cells: lessons from leukaemia.Target for cancer therapy: proliferating cells or stem cells.Neutrophil-selective CD18 silencing using RNA interference in vivoPutative cancer stem cells in cutaneous malignancies.The cancer stem cell paradigm: a new understanding of tumor development and treatment.An antiapoptotic Bcl-2 family protein index predicts the response of leukaemic cells to the pan-Bcl-2 inhibitor S1.Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemiaATP-binding-cassette transporters in hematopoietic stem cells and their utility as therapeutical targets in acute and chronic myeloid leukemia.Hematopoietic developmental pathways: on cellular basis.Aberrant cytokine signaling in leukemia.BCR-ABL-transformed GMP as myeloid leukemic stem cells.Re-evaluating the role of BCR/ABL in chronic myelogenous leukemiaCancer stem cells in breast: current opinion and future challenges.Targeting the leukemic stem cell: the Holy Grail of leukemia therapyMolecular biology of bcr-abl1-positive chronic myeloid leukemia.Expression of BCR/ABL p210 from a knockin allele enhances bone marrow engraftment without inducing neoplasiaBcl-xL anti-apoptotic network is dispensable for development and maintenance of CML but is required for disease progression where it represents a new therapeutic target.Persistence of leukemia-initiating cells in a conditional knockin model of an imatinib-responsive myeloproliferative disorder.FLT3-ITD up-regulates MCL-1 to promote survival of stem cells in acute myeloid leukemia via FLT3-ITD-specific STAT5 activation.A neurosurgeon's guide to stem cells, cancer stem cells, and brain tumor stem cells.NPMc+ cooperates with Flt3/ITD mutations to cause acute leukemia recapitulating human disease.Transcriptional activation of hypoxia-inducible factor-1 (HIF-1) in myeloid cells promotes angiogenesis through VEGF and S100A8.A Pan-BCL2 inhibitor renders bone-marrow-resident human leukemia stem cells sensitive to tyrosine kinase inhibition.Cancer stem cells and cancer therapy.
P2860
Q24658222-0A9EEEBF-6783-47CB-B74D-90B9F7E0F250Q24811898-50FB956E-1556-4E9D-B851-45005A650C36Q26859782-8AE525B2-EDC7-4C58-8790-BB58C2E22E56Q29622952-59A2F995-1523-4E4B-A265-98C6BE80EAD1Q30439716-92F08646-7C8B-4179-B34F-DCE933D1E409Q33968037-F670455D-9015-460F-826A-85F2A0752401Q34193548-E39AE318-4EE5-446A-9E87-E6EB87B22248Q34542144-75CFA65D-2E01-4A86-BA65-A00F16102DCCQ34553348-07861D71-4C74-4105-841A-D49B32AC2D2BQ34597509-84AEF573-48F9-4BCD-A9E0-EAA0AF6B7277Q35132225-0649CEBF-6D32-42DB-BD03-CE0222D0C74AQ35847760-AA262038-F970-4044-B448-7B0B882C6C96Q35944295-FC9F0F89-5A8B-460A-A761-E6C3DFCAA951Q36038002-1F5DE513-654D-49E0-94B9-08783BBB61F1Q36079782-7315787C-4D90-463D-A3AD-D006C748EFEDQ36228053-E5367823-E035-4922-AB54-35AF4240CF97Q36318587-E65D4283-9E03-48BD-81D9-F6E27383216AQ36343524-D0F025C8-9E4A-4194-9EF0-BAFAA4575957Q36508905-27ADAD4F-D273-4D0C-92CC-7323AC1321BCQ36759571-D251A9FC-87EC-4C55-8FA9-EAF2E2C87915Q36854372-AA5D00A9-2C3F-4AD2-83B6-EE1D411A0FB0Q36857524-D9B480DC-6C8C-4CA6-B5E5-3F45FFE12CD5Q36883073-44232744-08BD-4159-BB9A-24AE5E9CE160Q36893545-5692ABD1-5372-49D0-93A0-910D2C2AE61CQ36970175-3E72D5D0-DA0C-40ED-85DC-D8A02DBD9336Q36970192-FD4388DB-0177-4269-B406-C711BBC15EBEQ36970694-3748D5A7-A724-407C-9BD6-8AE216D04868Q36997520-503D2BDE-B1B0-485B-859A-92FAAE696BBBQ37188273-8918B791-6E13-4785-8039-D409596782CEQ37272565-1E3EB695-5D1B-4C62-ABDA-7C1D54044E3AQ37283128-26CD3540-EC3F-48A0-A292-20E6C54D8098Q37320065-32736C54-910F-4BB8-B616-297BB1C49963Q37322437-8528C1A9-6A20-49C5-B27A-C0786098B03BQ37390598-F314A6CD-AC85-4DF5-B010-F0EB9E631609Q37460343-9A8C95B8-8033-46EF-A97C-CD178109145CQ37559173-6C384A47-5D27-4991-BE60-D728D6BE5A9DQ37599556-C1533EB3-244E-4E49-9B6B-94E066C8AC45Q37599900-B8418CF1-8C11-45A9-868E-1145E36992C9Q37670967-2FD254DA-1312-4AC1-BBEE-DF9DFB51C2F8Q37841186-FA3A1251-8576-49A2-94D6-1A83186A431D
P2860
Expression of BCR/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias.
description
2003 nĆ® lÅ«n-bĆ»n
@nan
2003幓ć®č«ę
@ja
2003幓č«ę
@yue
2003幓č«ę
@zh-hant
2003幓č«ę
@zh-hk
2003幓č«ę
@zh-mo
2003幓č«ę
@zh-tw
2003幓č®ŗę
@wuu
2003幓č®ŗę
@zh
2003幓č®ŗę
@zh-cn
name
Expression of BCR/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias.
@ast
Expression of BCR/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias.
@en
type
label
Expression of BCR/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias.
@ast
Expression of BCR/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias.
@en
prefLabel
Expression of BCR/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias.
@ast
Expression of BCR/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias.
@en
P2093
P2860
P356
P1476
Expression of BCR/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias.
@en
P2093
David Traver
Eric Lagasse
Irving L Weissman
Koichi Akashi
Siddhartha Jaiswal
Toshihiro Miyamoto
P2860
P304
10002-10007
P356
10.1073/PNAS.1633833100
P407
P577
2003-07-30T00:00:00Z